Thailand has been at the forefront in the fight against HIV/AIDS, with notable strides made in treatment strategies. Despite the high prevalence of HIV in the country, advancements in antiretroviral therapy (ART) and evolving healthcare policies have paved the way for improved patient outcomes. However, the journey towards achieving universal HIV treatment in Thailand is far from over. This article delves into Thailand’s efforts in HIV treatment, shedding light on the successes, challenges, and future directions.
Image Source: Unsplash
The Prevalence of HIV in Thailand
The Human Immunodeficiency Virus (HIV) has been a significant health concern in Thailand for decades. In 2020, approximately 500,000 individuals were estimated to be living with HIV in the country, signifying one of the highest prevalence rates in the region. The epidemic, although declining, continues to persist, particularly among young people and key affected populations. The high-risk groups include those who engage in unprotected sex, sex workers, and people who inject drugs.
Despite the high prevalence, Thailand has made commendable progress in controlling the disease. Around 94% of people living with HIV in Thailand are aware of their status. Furthermore, AIDS-related deaths have significantly declined, with new infections falling by 58% since 2020.
The Importance of Early Diagnosis and Treatment
Early diagnosis and treatment initiation are crucial in managing HIV and preventing its progression to Acquired Immunodeficiency Syndrome (AIDS), a severe stage of the disease where the immune system is almost completely devastated. Research indicates that people who inject drugs are 35 times more likely to acquire HIV due to risky behaviors, such as sharing of needles. However, late diagnosis and delayed treatment initiation remain significant challenges in Thailand, leading to poor patient outcomes and high mortality rates.
A study conducted by Dr. Weerawat Manosuthi at Bamrasnaradura Infectious Diseases Institute revealed a survival rate of just 75% among people living with HIV who initiated ART within five years of diagnosis. The study highlighted the need for interventions that promote early HIV diagnosis and treatment initiation to improve patient outcomes and survival rates.
The Shift to Dolutegravir (DTG)
Thailand, like many other low- and middle-income countries, has begun the ‘switch’ from older HIV treatments to the World Health Organization’s (WHO) preferred first-line regimens containing Dolutegravir (DTG). DTG is favored due to its better tolerability, fewer drug interactions, and once-daily dosage. Research data also shows that treatment with DTG leads to better HIV viral load suppression, particularly among people who start with high viral loads.
The Thai government plans to switch 80% of those currently on antiretroviral treatments to a DTG-containing regimen by the end of the year, representing approximately 300,000 people. This switch has been made possible due to Thailand’s inclusion of DTG and tenofovir/lamivudine/dolutegravir (TLD) combined formulation in its Essential Medicines List.
Considerations for DTG in Thailand
Despite the promising prospects of DTG, there are several considerations for its widespread use in Thailand. Firstly, generic DTG needs to be registered locally to be part of the tender process, procured, and supplied. Currently, Thailand has only one brand of DTG registered for adults. This lack of local suppliers has led to a shortfall in drug availability and exorbitant pricing.
Secondly, a significant proportion of people who inject drugs in Thailand are not enrolled in antiretroviral therapy (ART), which is used to treat HIV. Efforts are needed to increase ART enrollment among this population to maximize the benefits of the DTG switch.
Lastly, civil society groups in Thailand involved in advocacy work supporting the roll-out of DTG would benefit from access to country-by-country information on products seeking global registrations through the WHO Collaborative Registration Procedure (CRP). This information would help local civil society groups advocate for accelerating the registration process at the national level.
The New Narcotics Law and Its Impact
A new narcotics law introduced in Thailand in December 2021 has shifted the narrative around people who use drugs in a positive way. Historically, Thailand has had very punitive laws that criminalize drug offenders. The new law provides for differentiated sentencing on drug crimes and alternatives to imprisonment for some offenses. For the first time, it seems the health and wellbeing of people who use drugs are being considered. This change in the legal framework, coupled with reduced stigma and discrimination, is essential in encouraging people who use drugs to seek treatment, including for HIV.
The Role of Universal Health Coverage (UHC)
A significant transformation of Thailand’s health system has occurred with the introduction of Universal Health Coverage (UHC) in 2002. UHC has paved the way for comprehensive care, including essential services like HIV testing, pre-exposure prophylaxis (PrEP), treatment referrals, and screening and treatment for sexually transmitted infections (STIs) and Hepatitis C. UHC encourages more people to get tested and treated, thereby improving health outcomes for people living with HIV in Thailand.
Thailand’s Commitment to Ending HIV
Thailand has shown a strong commitment to ending HIV. The Ministry of Public Health has set a goal to reduce AIDS mortality to fewer than 4,000 deaths per year by 2030. To achieve this goal, the Thai government is working closely with UN agencies to improve the availability of HIV services and reduce the stigmatization of people who use drugs.
Furthermore, Thailand has been focusing on supporting the underserved groups by promoting community-led services. These services must be delivered close to the people who need them in a situation where the clients do not feel stigmatized. This approach has been instrumental in creating both equitable access to services and the integration of services.
In conclusion, Thailand’s efforts in HIV treatment signify a beacon of hope in the fight against HIV/AIDS. While challenges remain, the country’s commitment to improving HIV treatment, coupled with advancements in antiretroviral therapy and evolving healthcare policies, brings us one step closer to a world where HIV is no longer a threat to health or happiness.
